Why Diabetes Stock Insulet Jumped 13.3% in January -- After Soaring 116% in 2019
Shares of Insulet (NASDAQ: PODD) surged 13.3% last month, according to data from S&P Global Market Intelligence. The S&P 500 was flat in January. The Boston-area healthcare company is the leader in tubeless insulin pump technology with its Omnipod pump.
Insulet stock has continued to move higher in February, bringing its 2020 gain to 15.9% through Feb. 6, versus the broader market's 3.7% return. The stock was a huge winner last year, handing investors a gain of 116%, compared with the S&P 500's 31.5% return. (In October, I picked Insulet as one of "three stocks poised for huge growth over the next decade.")
Image source: Getty Images.
Source Fool.com
